Chlamydia pneumoniae infection as a risk factor for accelerated Atherosclerosis in hemodialysis patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 3, 2010, Pages 367-375

  Schiavoni, G ^a   Di Pietro, M ^a   Ronco, C ^b   De Cal, M ^b   Cazzavillan, S ^b   Rassu, M ^b   Nicoletti, M ^c   Del Piano, M ^b   Sessa, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerotic cardiovascular disease; Chlamydia pneumoniae; End stage renal disease; Inflammatory markers; Peripheral blood mononuclear cells; Real time PCR

Indexed keywords

BACTERIAL DNA; C REACTIVE PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 6;

ADULT; ARTICLE; ATHEROSCLEROSIS; BACTERIAL GENE; BACTERIUM EXAMINATION; BLOOD DONOR; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; OMPA GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; AGED; BLOOD; CHLAMYDIASIS; COMPLICATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; RENAL REPLACEMENT THERAPY;

CHLAMYDOPHILA PNEUMONIAE;

AGED; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RENAL DIALYSIS;

EID: 77957892394     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol 2009; 5:287-96.
2. Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:899-1911.
3. Stenvinkel P, Heimbürger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002; 39:274-82.
4. Kato A, Odamaki M, Takita T, Furuhashi M, Maruyama Y, Hishida A. C-reactive protein is a predictor of short-term mortality in haemodialysis patients. Am J Nephrol 2001; 21:176-78. (Pubitemid 32453699)
5. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A. Association between interleukin-6 and carotid atheroslerosis in hemodialysis patients. Kidney Int 2002; 61:1143-52. (Pubitemid 34175483)
6. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP. Overproduction of reactive oxygen species in end-stage renal disease patients: A potential component of hemodialysis-associated inflammation. Hemodialysis Int 2005; 9:37-46.
7. Lonnemann G, Haubits M, Scindler R. Haemodialysis-associated induction of cytokines. Blood Purif 1990; 8:214-22.
8. Sessa R, Cipriani P, Di Pietro M, Schiavoni G, Santino I, del Piano M. Chlamydia pneumoniae and chronic diseases with a great impact on public health. Int J Immunopathol Pharmacol 2008; 21:1041-3.
9. Kern JM, Maass V, Maass M. Chlamydia pneumoniae- induced pathological signaling in the vasculature. FEMS Immunol Med Microbiol 2009; 55:131-9.
10. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, del Piano M, Cipriani P. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 2009; 22:9-14.
11. Gaydos CA. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 2000; 81:S473-78.
12. Di Pietro M, Schiavoni G, del Piano M, et al. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. J Biol Regul Homeost Agents 2009; 23:65-9.
13. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65.
14. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-8.
15. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-918.
16. Lentine KL, Parsonnet J, Taylor I, Wrone EM, Lafayette RA. Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol 2006; 10:55-62.
17. Wszola M. Kwiatkowski A, Nosek R, et al. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients. Transplant Proc 2006; 38:31-4. (Pubitemid 43303591)
18. Yavuz MT, Yavuz O, Yazici M, Guler S, Ozhan H, Albayrak S, Coskun A. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis. Scand J Clin Lab Invest 2006; 66:523-34. (Pubitemid 44454449)
19. Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, Nicoletti M, Santino I, del Piano M.. Measurement of Chlamydia pneumoniae bacterial load in peripheral mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007; 195:e224-30.
20. Sessa R, Schiavoni G, Di Pietro M, Petrucca A, Cipriani P, Puopolo M, Zagaglia C, Fallucca S, Del Piano M. Chlamydia pneumoniae in PBMC: reproducibility of the ompA nested touchdown PCR. Int J Immunopathol Pharmacol 2005; 18:113-20.
21. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-38.
22. Miyata T, Van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of carbonyl stress in long-term uremic complications. Kidney Int 1999; 55:389-99. (Pubitemid 29082866)
23. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol 1990; 186:464-78.
24. Dini L, Coppola S, Ruzittu MT, Ghibelli L. Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res 1996; 223:340-47. (Pubitemid 26089091)
25. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance of dialysis patients. Kidney Int 2003; 63:793-808. (Pubitemid 36315558)
26. Marzioni D, Lorenzi T, Mazzucchelli R, et al. Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol 2009; 22:627-38.
27. Castellani ML, Felaco P, Pandolfi F, et al. Inflammatory compounds: neuropeptide substance P and cytokines. Eur J Inflamm 2009; 7:63-70.
28. Lima DS, Zárate-Bladés CR, Souza PRM, et al. No evidence of pathological autoimmunity following Mycobacterium leprae heat-shock protein 65-DNA vaccination in mice. Eur J Inflamm 2009; 7:77-86.
29. Beddhu S. The paradox of the "body mass index paradox" in dialysis patients: associations of adiposity with inflammation. Am J Clin Nutrition 2005; 82:909-10.
30. Bergström J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 2000; 13:163-75.
31. Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T. Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 2008; 23:1697-703.
32. Rollino C, Massara C, Besso L, et al. Carotid intima-media thickness and anti-phospholipid antibodies in patients with systemic lupus erythematosus. Eur J Inflamm 2009; 7:19-24
33. Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols. Int J Immunopathol Pharmacol 2009; 22:1001-7.
34. D'Ercole S, Tetè S, Catamo G, Sammartino G, Femminella B, Tripodi D, Spoto G, Paolantonio M. Microbiological and biochemical effectiveness of an antiseptic gel on the bacterial contamination of the inner space of dental implants: a human 3-month longitudinal study. Int J Immunopathol Pharmacol 2009; 22:1019-26.
35. Fábián TK, Gótai L, Beck A, Fábián G, Fejérdy P. The role of molecular chaperones (HSPAs/HSP70s) in oral health and oral inflammatory diseases: a review. Eur J Inflamm 2009; 7:53-61.
36. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int 2008; 28:S183-7.
37. Fernandez GC, Ramos MV, Gomez SA, et al. Differential expression of function-related antigens on blood monocytes in children with haemolytic uremic syndrome. J Leukocyte Biology 2005; 78:853-61.